Pamela Stephenson, Chief Commercial Officer at ALBIREO PHARMA, INC. (ALBO), sold 461 shares at $19.47 ($9K) on 2022-06-27, disclosed to the SEC on 2022-06-28.
Scheduled sale ($9k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ZYNE | SELL | 2023-06-15 | $40 | — | Filing → |
| ALBO | SELL | 2023-01-23 | $4K | — | Filing → |
| ALBO | SELL | 2023-01-20 | $156K | — | Filing → |